Mandate

Vinge advises EQT VIII in connection with the acquisition of Recover Nordic

December 10, 2019 M&A

Vinge has advised EQT VIII in connection with the acquisition of Recover Nordic from funds advised by Agilitas Private Equity.

Recover Nordic is a Nordic market leader in property remediation and environmental services, primarily serving insurance companies, municipalities, industrial- and commercial clients. Headquartered in Oslo, Norway and with more than 90 branches across the Nordics, the Company has over 2,100 employees and is expected to generate revenues of NOK 3.0 billion in 2019.

The transaction is expected to close in the first quarter of 2020.

Vinge’s team consisted of Daniel Rosvall, Johanna Wiberg, Christian Brelin and Ellinor Wargenbrant (M&A), Johan Cederblad and Cornelia Medrek (Environment), Josefine Lanker and Axel Jansson (Banking and Financing), Mathilda Persson, Rebecka Maltenius, Martin Boström and Lisa Hörnqvist (Commercial Agreements and IT), Emma Johansson (Competition and Regulatory), Lisa Ullman and Ebba Svenburg (Employment) and Kristoffer Larson (Real Property).

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026